Maintenance Notice (5:30 AM - 12:00 PM December 21, 2024): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.197
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 190728-25-7 | Product Number: D5070
4-[(6,7-Dimethoxyquinolin-4-yl)oxy]aniline
×
![]()
×
![4-[(6,7-Dimethoxyquinolin-4-yl)oxy]aniline](/_ui/responsive/theme-tci/images/missing_product_zoom.jpg "4-[(6,7-Dimethoxyquinolin-4-yl)oxy]aniline")
Purity:
Synonyms:
- 4-(4-Aminophenoxy)-6,7-dimethoxyquinoline
Product Documents:
| Size | Unit Price | Belgium | Japan* | Quantity |
|---|---|---|---|---|
| 200MG |
£74.00
|
1 | 8 |
|
| 1G |
£265.00
|
1 | 14 |
|
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
| Product Number | D5070 |
| Molecular Formula / Molecular Weight | C__1__7H__1__6N__2O__3 = 296.33 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| CAS RN | 190728-25-7 |
| Reaxys Registry Number | 1490304 |
| PubChem Substance ID | 354334606 |
| MDL Number | MFCD19685633 |
Specifications
| Appearance | Light yellow to Brown powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 95.0 % |
| Melting point | 211.0 to 215.0 °C |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 214 °C |
GHS
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H315 : Causes skin irritation. H319 : Causes serious eye irritation. |
| Precautionary Statements | P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ eye protection/ face protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. |
Related Laws:
Transport Information:
| HS Number | 2933499090 |
Application
A Synthetic Intermediate of VEGFR-2 Tyrosine Kinase Inhibitors and PDGFR Tyrosine Kinase Inhibitors
This reagent has been used for the synthesis of vascular endothelial growth factor receptor-2 (VEGFR-2) tyrosine kinase inhibitors such as cabozantinib [CAS: 849217-68-1],1-3) and platelet-derived growth factor receptor (PDGFR) tyrosine kinase inhibitors.4,5)
References
- 1)Novel Potent Orally Active Selective VEGFR-2 Tyrosine Kinase Inhibitors: Synthesis, Structure-Activity Relationships, and Antitumor Activities of N-Phenyl-N'-{4-(4-quinolyloxy)phenyl}ureas
- 2)N-(4-(6,7-Disubstituted-quinolin-4-yloxy)-3-fluorophenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: A novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitors
- 3)Degradation kinetics study of cabozantinib by a novel stability-indicating LC method and identification of its major degradation products by LC/TOF-MS and LC-MS/MS
- 4)Synthesis and structure-activity relationship for new series of 4-phenoxyquinoline derivatives as specific inhibitors of platelet-derived growth factor receptor tyrosine kinase
- 5)Identification of Potent and Selective Inhibitors of PDGF Receptor Autophosphorylation
PubMed Literature
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.